Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains.
about
Identification of the cellular prohibitin 1/prohibitin 2 heterodimer as an interaction partner of the C-terminal cytoplasmic domain of the HIV-1 glycoproteinRNA dimerization defect in a Rous sarcoma virus matrix mutant.The Nef protein of human immunodeficiency virus type 1 enhances serine phosphorylation of the viral matrixUnderstanding the process of envelope glycoprotein incorporation into virions in simian and feline immunodeficiency virusesThe role of matrix in HIV-1 envelope glycoprotein incorporationNucleocapsid promotes localization of HIV-1 gag to uropods that participate in virological synapses between T cellsCoronavirus particle assembly: primary structure requirements of the membrane protein.Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assemblyA leucine zipper motif in the cytoplasmic domain of gp41 is required for HIV-1 replication and pathogenesis in vivoMolecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization.Mutational analysis of the hydrophobic tail of the human immunodeficiency virus type 1 p6(Gag) protein produces a mutant that fails to package its envelope protein.Opposing effects of human immunodeficiency virus type 1 matrix mutations support a myristyl switch model of gag membrane targeting.Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle.Cleavage of the murine leukemia virus transmembrane env protein by human immunodeficiency virus type 1 protease: transdominant inhibition by matrix mutations.Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and alpha-helix 2 of the gp41 cytoplasmic tail.Cell-dependent requirement of human immunodeficiency virus type 1 gp41 cytoplasmic tail for Env incorporation into virionsMutational analysis of conserved domains within the cytoplasmic tail of gp41 from human immunodeficiency virus type 1: effects on glycoprotein incorporation and infectivity.Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyproteintrans-dominant interference with human immunodeficiency virus type 1 replication and transmission in CD4(+) cells by an envelope double mutant.Cyclosporine blocks incorporation of HIV-1 envelope glycoprotein into virions.Localization of human immunodeficiency virus type 1 Gag and Env at the plasma membrane by confocal imaging.Efficient HIV-1 replication can occur in the absence of the viral matrix protein.Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail.Amino acid residues in the cytoplasmic domain of the Mason-Pfizer monkey virus glycoprotein critical for its incorporation into virions.Cell surface expression of the HIV-1 envelope glycoproteins is directed from intracellular CTLA-4-containing regulated secretory granules.Virus particle release from glycosphingolipid-enriched microdomains is essential for dendritic cell-mediated capture and transfer of HIV-1 and henipavirus.The tale of the long tail: the cytoplasmic domain of HIV-1 gp41.Mutation of the dominant endocytosis motif in human immunodeficiency virus type 1 gp41 can complement matrix mutations without increasing Env incorporationEnvelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virusA mutation in the human immunodeficiency virus type 1 Gag protein destabilizes the interaction of the envelope protein subunits gp120 and gp41.Evidence for a functional link between uncoating of the human immunodeficiency virus type 1 core and nuclear import of the viral preintegration complex.Super-resolution microscopy reveals specific recruitment of HIV-1 envelope proteins to viral assembly sites dependent on the envelope C-terminal tail.Determinants of increased replicative capacity of serially passaged simian immunodeficiency virus with nef deleted in rhesus monkeys.Tail-interacting protein TIP47 is a connector between Gag and Env and is required for Env incorporation into HIV-1 virionsHIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation.Systematic analysis of intracellular trafficking motifs located within the cytoplasmic domain of simian immunodeficiency virus glycoprotein gp41Role of the HIV-1 Matrix Protein in Gag Intracellular Trafficking and Targeting to the Plasma Membrane for Virus Assembly.Efficiency of human immunodeficiency virus type 1 postentry infection processes: evidence against disproportionate numbers of defective virions.A highly conserved residue in the C-terminal helix of HIV-1 matrix is required for envelope incorporation into virus particlesHIV cell-to-cell transmission requires the production of infectious virus particles and does not proceed through env-mediated fusion pores.
P2860
Q24316304-D1D8C095-09EF-42ED-B11C-9968EBF71955Q24524289-45B0EB7F-AE69-470B-975E-D4A22508BD9AQ24673997-DCB1F1AD-3657-41CE-85F8-2797F16F71D0Q27021655-5B9164C1-338C-419F-B7E2-90C51A7D1700Q27023106-E4925D2B-3E5F-483C-B2B2-E974FE93E30CQ27312753-96E342C5-E36F-43A1-B3FF-4C802BFB0B4DQ27469560-767B5B94-2CE2-4D3B-8E79-8D3616C005D4Q27732646-FE0337BA-4C4C-41C3-BC42-2A8F67355CA8Q28363049-2D43A9FA-9718-49C0-8578-7193BD4F77D8Q30423779-1613A050-C461-41B3-9E85-8BCD541DFD82Q33638655-B8DD47CF-B22C-4100-9FE8-950586B072DBQ33642818-D8BA4409-2EF4-4FE0-962A-EFD6453F76A5Q33782781-F4E8D659-77C8-4EFB-9817-4EC0291EF54FQ33785977-4A33BCD0-C9E8-4E89-AE17-DB7FE0408911Q33802126-88F63387-B73E-4A51-968D-5DF1715F917DQ33805110-9A3E37CB-2CF5-46ED-B5DE-97544AEBC2B8Q33812739-B57E6F01-24E8-4BDA-87D1-DED2DB01EB19Q33814996-F9A90D58-4A42-46C7-8731-1B25B5C90D57Q33819782-F5833758-8E17-4217-BDDB-391C7124B6C6Q33826603-81DF68F2-3DD6-4B9B-948D-BD42070EF478Q33874415-585EE07B-A6CB-44E8-B63D-21C206DFC641Q33888825-89150941-C829-4F77-8257-0E88497F4E1AQ33984243-D440F80A-3FF4-4414-A03D-A3E4D127628CQ33987373-AE6D7B9A-3D05-4942-A53D-2BC7F5D9F7E0Q34030981-E1A06FFB-859E-48AC-9EEF-AC0904F0B690Q34059163-35F88D23-6563-4F9C-B0D3-56E8DDCDA74FQ34306883-1FA7A500-778B-4C52-A888-EEE440AF26D5Q34333514-9E1D609E-3BD7-40C7-904C-CB0BF43D9A7BQ34364045-9D751C40-353E-48A7-938B-0585B103B18BQ34434813-2034A4D6-1782-40BB-B3F8-BB943398EEB4Q34546004-CF391545-43E2-4992-84B9-AA970D4E4C19Q34611178-43A79BA0-CAA4-4706-93F4-CF0DB24BD793Q35020270-99347C20-6271-4832-88AF-9017B69E2366Q35075569-0120E109-7102-4914-B621-EB611F29FE1DQ35113720-ECC6C7F5-BE50-4861-AFF2-F518574BE328Q35494155-33F7DF40-2E78-4767-8468-00FF731F47B9Q35761675-BC1097D6-0BD8-4AFB-8E00-01CBAA28DA11Q35785356-C45C1D5B-0DD5-4AF1-B145-4ED426911671Q35826475-A85A112D-D570-4C87-9B63-B1FDF4BF37E5Q35826780-A9F5DA74-C04E-486A-BE7D-06D53C1E05D7
P2860
Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Rescue of human immunodeficien ...... ith short cytoplasmic domains.
@ast
Rescue of human immunodeficien ...... ith short cytoplasmic domains.
@en
type
label
Rescue of human immunodeficien ...... ith short cytoplasmic domains.
@ast
Rescue of human immunodeficien ...... ith short cytoplasmic domains.
@en
prefLabel
Rescue of human immunodeficien ...... ith short cytoplasmic domains.
@ast
Rescue of human immunodeficien ...... ith short cytoplasmic domains.
@en
P2093
P2860
P1433
P1476
Rescue of human immunodeficien ...... with short cytoplasmic domains
@en
P2093
A Bukovsky
H G Göttlinger
P2860
P304
P407
P577
1995-06-01T00:00:00Z